Introduction {#s1}
============

Although clinically under-recognised, the 22q11.2 deletion syndrome (22q11.2DS) is the most common microdeletion disorder with an estimated prevalence of 1 in 2000--4000 live births. Individuals with 22q11.2DS most often have a classically associated 3 MB deletion. However, smaller atypical nested deletions have been reported, all of which result in a broad spectrum of phenotypic abnormalities.[@R1] [@R2] The occurrences of deletions in this region are related to the architecture of chromosome 22q11.2 and are associated with a non-allelic homologous recombination between chromosome specific low copy repeats (LCRs) or segmental duplications.[@R3] The larger 3 MB deletion is associated with recombination between LCRs-A and D. Furthermore, although the smaller atypical nested deletions are predominantly mediated by LCRs A-B, they also include deletions involving LCRs B-D or C-D. In general, the associated clinical findings include: congenital cardiac abnormalities, palatal anomalies, and immunodeficiency in about three-quarters of patients; hypoparathyroidism in approximately half; and gastrointestinal and renal anomalies in about one-third.[@R4; @R5; @R6] Additional findings can confer significant morbidity, such as autoimmune disease and skeletal anomalies, but are generally identified in only a subset of patients.[@R7] Lastly, developmental delay, intellectual deficits, and psychiatric disorders such as schizophrenia are important features of this diagnosis.[@R8]

Although as many as 40 genes are deleted in patients with 22q11.2DS, mouse models of 22q11.2DS support a strong role for haploinsufficiency of *TBX1*, a T-Box gene in the A-B deleted region. *TBX1* has been implicated in association with several clinical findings, in particular congenital heart disease.[@R9] In patients with atypical deletions that do not include *TBX1,* the adaptor protein *CRKL* has emerged as a strong candidate for additional associated features.[@R10] In addition, a significant number of patients with 22q11.2DS have less common findings such as polymicrogyria, myelomeningocele, cleft lip, and genitourinary abnormalities that cannot be explained solely by haploinsufficiency for *TBX1* and/or *CRKL*. However, 22q11.2DS is considered a contiguous gene deletion syndrome as it has been proposed that loss of several or all genes within the region may contribute to the broad phenotype observed in patients.[@R11]

Next-generation sequencing advances, such as whole exome sequencing, enables identification of rare variants that may be damaging and therefore disease producing.[@R12] This new technology permits examination of the genome including the non-deleted allele for mutations that may contribute to variable phenotypic expression in deletion syndromes. Thus, we utilised whole or targeted exome sequencing in patients with a 22q11.2 deletion and phenotypic features found in \<10% of affected individuals and identified damaging mutations in *SNAP29*, the gene implicated in the autosomal recessive condition cerebral dysgenesis, neuropathy, ichthyosis and keratoderma (CEDNIK).[@R13] [@R14] *SNAP29* is located within the C-D region on chromosome 22q11.2. Heterozygous mutations of *SNAP29* have also been reported in association with cryptorchidism and hypospadias.[@R15] Furthermore, single nucleotide polymorphisms (SNPs) in the promoter of *SNAP29* have been associated with schizophrenia.[@R16]

SNAP29 (synaptosomal associated protein 29KDa) is a soluble SNARE protein that is predicted to mediate vesicle fusion at the endoplasmic reticulum or Golgi membranes.[@R17] SNAP29 was shown to be highly expressed in myelinating glia[@R18] and is required for lamellar body formation in the skin. It is also indirectly required for β1 integrin endocytosis and cell migration.[@R19] We report that hemizygous deletions of 22q11.2, combined with damaging mutations in *SNAP29*, contribute to atypical clinical findings in patients with 22q11.2DS. Specifically, this combination unmasks one previously described autosomal recessive condition (CEDNIK), and may unmask and confirm another condition previously debated in the literature (Kousseff syndrome). It also may provide an explanation for overlapping features with a third heterogeneous condition (Opitz G/BBB syndrome).

Patients and methods {#s2}
====================

The study was approved by the Institutional Review Board of the Children\'s Hospital of Philadelphia (07-005352) with appropriate informed consent obtained on all subjects. In addition, the study data were handled in compliance with HIPAA (Health Insurance Portability and Accountability  Act) regulations. We recruited individuals from The '22q and You' Center at The Children\'s Hospital of Philadelphia, a large comprehensive multidisciplinary programme for patients with 22q11.2DS, for inclusion in a study of atypical clinical findings (present in \<10% of overall cohort) at McGill University in Montreal, Canada and the University of Leuven in Leuven, Belgium. These findings initially included laryngo-tracheal-oesophageal abnormalities and limb differences, but were later expanded to include polymicrogyria, myelomeningocele, cleft lip, and genitourinary abnormalities. In total, 17 individuals with 22q11.2DS were studied ([table 1](#JMEDGENET2012101320TB1){ref-type="table"}). Whole exome sequencing was performed on four patients (patients 1, 5--7); targeted exome sequencing was performed on patient 4 and Sanger sequencing was used to screen for the presence of mutations within the gene *SNAP29* in 12 patients. A detailed synopsis of the clinical findings in the patients with mutations in *SNAP29* is provided in the supplementary data (patients 1--4).

###### 

A brief description of patients in this study

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient   CNS                    Cardiac                    Craniofacial                   Immune                   Eye/Ear                       Respiratory                                                 GI                       Dermatologic                GU                                             Other                               E/S   SNAP29M
  --------- ---------------------- -------------------------- ------------------------------ ------------------------ ----------------------------- ----------------------------------------------------------- ------------------------ --------------------------- ---------------------------------------------- ----------------------------------- ----- -----------------
  1         PMG\                   PDA                        SMCP\                          CI requiring IVIG\       ONH\                          LTM\                                                        Dysphagia and G-tube\    Palmoplantar keratoderma\   Cryptorchid\                                   --                                  E,S   c.388_389insGA
            Microcephaly                                      ASCF                           IgG and IgM deficiency   Nystagmus and esotropia\      OSA\                                                        Constipation\            Atopic dermatitis\          Inguinal hernia Idiopathic nephrocalcinosis\                                             
                                                                                                                      Hypertelorism\                Chronic peribronchial thickening with lung hyperinflation   FTT                      hypohidrosis                Hypercalciuria                                                                           
                                                                                                                      SNHL                                                                                                                                                                                                                                    

  2         PMG\                   --                         Preauricular tags              --                       ONH\                          Tracheomalacia                                              Dysphagia and G-tube\    Palmoplantar keratoderma\   Hypospadias                                    Type I DM\                          S     c.28_32delCCGTT
            Microcephaly                                                                                              Amblyopia and esotropia\                                                                  Constipation             Atopic dermatitis\                                                         Scoliosis                                 
                                                                                                                      Relative hypertelorism\                                                                                            hypohidrosis                                                                                                         
                                                                                                                      SNHL                                                                                                                                                                                                                                    

  3         Myelo Hydrocephalus\   TOF with PA                CP ASCF                        CI                       Hypertelorism\                Subglottic stenosis\                                        Dysphagia and G-tube\    --                          Hydronephrosis\                                Hypocalcaemia\                      S     c.265G\>A
            Microcephaly                                                                                              Astigmatism\                  Tracheostomy\                                               GORD\                                                Neurogenic bladder                             Clinodactyly                              
                                                                                                                      SNHL                          Asthma                                                      Constipation                                                                                                                                  

  4         --                     ASD/PFO                    BLCLP                          Low T cells              Hypertelorism\                --                                                          --                       --                          --                                             Hypocalcaemia\                      E     c.268C\>T
                                                                                                                      CDHL                                                                                                                                                                                          Hypermobile joints                        

  5         Migraines              Valvar pulmonic stenosis   VPI                            COM                      --                            Asthma                                                      Dysphagia and G-tube\    --                          --                                             Camptodactyly                       E     --
                                                                                                                                                                                                                GORD\                                                                                                                                         
                                                                                                                                                                                                                Constipation                                                                                                                                  

  6         Microcephaly\          Syncopal event             Lambdoidal craniosynostosis\   CI\                      Hypertelorism\                Laryngeal web\                                              GORD\                    --                          --                                             Short stature\                      E     --
            Migraines\                                        Bifid uvula                    Low IgM                  Lacrimal duct stenosis        Sleep apnoea\                                               Abdominal migraines\                                                                                Scoliosis\                                
            Seizures                                                                                                                                Asthma                                                      IBS                                                                                                 Hip dysplasia\                            
                                                                                                                                                                                                                                                                                                                    Adducted thumbs\                          
                                                                                                                                                                                                                                                                                                                    C-spine anomalies                         

  7         Hypotonia              --                         --                             COM                      --                            OSA\                                                        Dysphagia and NG tube\   --                          --                                             Short stature/low growth factors\   E     --
                                                                                                                                                    Asthma                                                      FTT                                                                                                 Camptodactyly\                            
                                                                                                                                                                                                                                                                                                                    Hypermobile joints                        

  8         Heterotopias\          BAV\                       ASCF\                          Haemolytic anaemia\      Hypertelorism                 --                                                          Dysphagia\               --                          Hydrocele\                                     Hypocalcaemia\                      S     --
            Seizures               AI\                        NR                             ITP\                                                                                                               GORD\                                                Inguinal hernia                                Postaxial 4 extremity polydactyly         
                                   Heart block                                               COM                                                                                                                Constipation                                                                                                                                  

  9         PMG\                   TA                         --                             CI                       --                            --                                                          Dysphagia\               --                          --                                             Hypocalcaemia                       S     --
            Hypotonia                                                                                                                                                                                           G-tube\                                                                                                                                       
                                                                                                                                                                                                                GORD                                                                                                                                          

  10        Myelo Hydrocephalus\   TOF with PA                NR                             COM                      CDHL                          Recurrent aspiration                                        Dysphagia and G-tube     --                          --                                             --                                  S     --
            Seizures                                                                                                                                                                                                                                                                                                                                          

  11        PMG                    VSD and PDA                NR                             COM and URIs             Eustachian tube dysfunction   Asthma                                                      Dysphagia and NG tube\   Mild atopic dermatitis\     --                                             Short stature\                      S     --
                                                                                                                                                                                                                GERD\                    Cutis aplasia on scalp                                                     Chronic leg pain                          
                                                                                                                                                                                                                Constipation                                                                                                                                  

  12        PMG\                   RAA\                       ASCF                           FUO\                     CDHL                          LTM\                                                        Dysphagia and G-tube\    --                          Solitary kidney                                Club foot\                          S     --
            Hypotonia\             ARSA\                                                     MRSA                                                   OSA\                                                        GORD\                                                                                               Hypermobile joints                        
            Seizures\              ASD                                                                                                              Asthma                                                      Constipation FTT                                                                                                                              
            Central apnoea                                                                                                                                                                                                                                                                                                                                    

  13        PMG\                   --                         ASCF\                          Low T cells              --                            Asthma                                                      Dysphagia\               --                          --                                             Hypocalcaemia\                      S     --
            Subarachnoid cyst\                                Nasal\                                                                                                                                            Constipation                                                                                        Thyroid disease\                          
            Hemiplegia                                        regurgitation                                                                                                                                                                                                                                         Hypermobile joints\                       
                                                                                                                                                                                                                                                                                                                    Anaemia                                   

  14        PMG\                   ARSA                       --                             --                       --                            Subglottic stenosis\                                        Imperforate anus\        --                          Hypoplastic kidney\                            Hip dysplasia                       S     --
            Seizures                                                                                                                                Laryngeal web                                               Dysphagia\                                           Vesicoureteral reflux\                                                                   
                                                                                                                                                                                                                G-tube\                                              Hypospadias and chordee\                                                                 
                                                                                                                                                                                                                GORD                                                 Penile scrotal transposition\                                                            
                                                                                                                                                                                                                                                                     Inguinal hernia                                                                          

  15        PMG\                   Vascular ring\             ASCF\                          --                       Astigmatism\                  OSA                                                         Dysphagia\               --                          --                                             Growth hormone deficiency\          S     --
            Hemiparesis            ASD                        Retrognathia                                            CDHL                                                                                      FTT                                                                                                 C-spine stenosis                          

  16        Heterotopias\          ASD/PFO\                   SMCP                           JRA                      SNHL                          --                                                          --                       --                          Duplicated collecting system                   Scoliosis                           S     --
            Seizures               PDA\                                                                                                                                                                                                                                                                                                                       
                                   ARSA                                                                                                                                                                                                                                                                                                                       

  17        Heterotopias\          RAA\                       VPI                            COM\                     --                            OSA\                                                        Dysphagia\               --                          --                                             Hypothyroid\                        S     --
            Seizures\              PFO                                                       IgM deficiency\                                        Sinusitis                                                   GORD\                                                                                               Obesity\                                  
            Hypotonia\                                                                       Pancytopenia                                                                                                       Constipation                                                                                        Cervical spine fusion                     
            Migraines                                                                                                                                                                                                                                                                                                                                         
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: all airway abnormalities were verified and found to be independent of vascular anomalies.

ASD, atrial septal defect; AI, aortic insufficiency; ARSA, aberrant right subclavian artery; ASCF, asymmetric crying facies; BAV, bicuspid aortic valve; BLCLP, bilateral cleft lip and palate; CP, cleft palate; CI, chronic infection; COM, chronic otitis media; CDHL, conductive hearing loss; C-spine, cervical spine; DM, diabetes mellitus; E/S, Exome (E) or Sanger (S) sequenced; FUO, fever of unknown origin; G-tube, gastrostomy tube; FTT, failure to thrive; GORD, gastro-oesophageal reflux disease; IVIG, intravenous immunoglobulins; ITP, idiopathic thrombocytopenia; IBS, irritable bowel syndrome; JRA, juvenile rheumatoid arthritis; LTM, laryngotracheomalacia; Myelo, myelomeningocele; MRSA, methicillin resistant *Staphylococcus aureus*; NR, nasal regurgitation; NG, nasogastric tube; OSA, obstructive sleep apnoea; ONH, optic nerve hypoplasia; PMG, polymicrogyria; PDA, patent ductus arteriosus; PA, pulmonary atresia; PFO, patent foramen ovale; RAA, right aortic arch; SMCP, submucosal cleft palate; SNHL, sensorineural hearing loss; SNAP29M, SNAP29 mutation present or absent; TOF, tetralogy of Fallot; TA, truncus arteriosus; URIs, upper respiratory infections; VSD, ventricular septal defect; VPI, velopharyngeal incompetence.

Whole exome sequencing and variant analysis {#s2a}
-------------------------------------------

Whole exome capture was performed using the TruSeq Exome Enrichment Kit (Illumina, San Diego, California, USA), which targets 62 Mb of exonic sequences including 5′ untranslated region (UTR), 3′UTR, microRNA and other non-coding RNAs. The targeted exons were sequenced using paired-end technology (Illumina Hiseq sequencer) with read lengths of 100 bp. The generated exome sequencing data were analysed using our optimised bioinformatics pipeline as previously described.[@R20] Briefly, the high quality trimmed paired-end sequences were aligned to the human reference genome (hg19) using Burrows-Wheeler Aligner (BWA) (v.0.5.9)[@R21] Unmapped reads, reads mapping to multiple locations and PCR duplicates (PICARD V.1.48) were discarded in further analyses. A mean coverage of 66X (patient 1), 91X (patient 5), 78X (patient 6), and 76X (patient 7) was obtained for all consensus coding sequence exons.

The variant positions on the reference genome were determined using Samtools (v.0.1.17),[@R22] mpileup and varFilter with the base alignment quality adjustment disabled, leading to the identification of approximately 299K (patient 1), 286K (patient 5), 265K (patient 6), and 269K (patient 7) variants. Additional filters were applied to narrow down the list of candidate rare variants. First, a minimum of two variant reads and \>20% single nucleotide variants or \>15% indels (small insertions or deletions) variant reads were considered for each called position. In order to remove systematic false positives and common polymorphisms, the variants were filtered against our in-house exome database (\>350 exomes) and removed from further analysis if seen in more than five control exomes.

Subsequently, ANNOVAR[@R23] was used to annotate the remaining variants according to the type of mutation, whether the variant was present in dbSNP132, minor allele frequency in the 1000 Genomes project, exome variant server (EVS), SIFT, PolyPhen-2 and PHASTCONS scores. Based on the assumption that the potential damaging variants are rare, the variants were kept in the final list if they had an allele frequency \<0.05 in the 1000 Genomes database and predicted to be non-synonymous, that is, missense, nonsense, frameshift, or canonical splice site changes. A summary of the data obtained from each step of exome sequencing analysis is presented in supplementary table 1.

Targeted exome sequencing and analysis {#s2b}
--------------------------------------

The mutation in patient 4 was identified using a custom Agilent SureSelect XT target enrichment system to capture the ∼3 Mb interval of the intact chr22q11.2. Sequencing was performed using the Illumina HiScan SQ platform with 50 bp paired end reads. The reads were mapped and annotated using the Emory Mapper (Cutler and Zwick, unpublished data) and the results were bioinformatically filtered to help ensure a low level of false-positive nucleotide calls.

Sanger sequencing and analysis {#s2c}
------------------------------

To screen the *SNAP29* gene, genomic DNA was extracted from whole blood using the Wizard Genomic DNA Purification Kit (Promega), following the manufacturer\'s instructions. All sequences, with the exception of exon 1, were amplified using 50 ng of genomic DNA and Platinum Taq Hifi DNA polymerase (Invitrogen), using the standard protocol and a T^m^ of 58°C. Exon 1 was amplified using Platinum Pfx DNA polymerase (Invitrogen), with a final concentration of 2× PCR~X~Enhancer Solution and a T^m^ of 55°C. Sanger sequencing was performed at the McGill University and Génome Québec Innovation Centre, using the forward primer on the unpurified PCR products. Resulting sequences were compared using BioEdit (<http://www.mbio.ncsu.edu/bioedit/bioedit.html>). Primers were designed by web-based Primer 3 (<http://primer3.sourceforge.net/>).

To determine the impact of novel amino acid substitutions on the SNAP29 protein, the PolyPhen-2 and MutationTaster tools were used.[@R24] [@R25]

Results {#s3}
=======

To identify additional mutations that contribute to atypical clinical findings in patients with 22q11.2DS, we used whole exome sequencing to analyse the genome of four patients presenting with laryngo-tracheal-oesophageal and limb abnormalities ([table 1](#JMEDGENET2012101320TB1){ref-type="table"}, patients 1, 5--7). Homozygous 22q11.2 -associated variants were identified in one of the four patients sequenced. In patient 1, we identified 539 variants that passed all the filters after whole exome sequencing analysis, 14 of which were located on chromosome 22. Two variants out of the 14 were homozygous within the candidate region of 22q11.2: one frameshift insertion within the gene *SNAP29*, and one non-synonymous variant in the gene *CLTCL1.* Although a significant number of variants were identified in the remaining three patients (13 homozygous variants in the exome of patients 5; 17 in the exome of patient 6; and 45 in the exome of patient 7), none were in the 22q11.2 region (see supplementary table 1).

Patient 1 presented with a history of laryngotracheomalacia, a small patent ductus arteriosus, gastro-oesophageal reflux disease, failure to thrive and feeding difficulty requiring G-tube placement, chronic infection, polymicrogyria, and dysmorphic features including hypertelorism. In addition, he had: microcephaly, strabismus, optic nerve hypoplasia, bilateral sensorineural hearing loss, obstructive sleep apnoea, immunoglobulin G (IgG) and IgM deficiency, a unilateral inguinal hernia and undescended testis. More recently, he was noted to have palmoplantar keratoderma and ichthyosis, ([figure 1](#JMEDGENET2012101320F1){ref-type="fig"}: 1A--F). The homozygous frameshift insertion within *SNAP29*, c.388_389insGA (p.T130fs), has not previously been seen in dbSNP, 1000 Genomes Project or EVS, and was subsequently confirmed by Sanger sequencing ([figure 2](#JMEDGENET2012101320F2){ref-type="fig"}A--C). Sanger sequencing of parental blood DNA revealed a heterozygous insertion in the father at the same position ([figure 2](#JMEDGENET2012101320F2){ref-type="fig"}C), suggesting that the proband was hemizygous for the 22q11.2 chromosome, as determined by fluorescence *in situ* hybridisation. (FISH), and inherited a non-functional *SNAP29* gene from the father and by inference a de novo deletion on the 22q11.2 chromosome inherited from his mother. Truncating mutations in *SNAP29* are associated with CEDNIK syndrome, an autosomal recessive condition characterised by cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma.[@R14] [@R15] The frameshift mutation identified in *SNAP29* is predicted to result in a truncated protein with 129 amino acids of the *SNAP29* protein, and insertion of 17 novel amino acids before a premature stop ([figure 2](#JMEDGENET2012101320F2){ref-type="fig"}C).

![Patient description. (1A) Patient 1--- Anteroposterior (AP) photo demonstrating upslanting palpebral fissures with hooded eyelids and hypertelorism; malar flatness; a bulbous nasal tip with hypoplastic alae nasi; and a mandibular cleft. (1B) Lateral photo demonstrating auricular anomalies including thick crumpled helices with attached lobes. (1C) A 2 mm thick T1 axial image of the brain reveals pronounced under-opercularisation with very wide Sylvian fissures and bilateral thick finely nodular cortex, consistent with polymicrogyria, throughout the brain but being particularly thick in the insular regions. There is abnormal brain morphology with some gyri being small and some wide. Also, there is diminished white matter and there are multiple anomalous deep fissures in both parieto-occipital regions that extend near to and deform the atria of the lateral ventricles, particularly on the right. The *genu* of the corpus callosum is unusually thick and the splenium is very thin. (1D) A focal area of frictional alopecia on the vertex. (1E) Right foot displays a diffuse keratoderma with erythema and thick desquamating hyperkeratotic sheets localised to the plantar surface of the foot and toes. (1F) Right hand shows diffuse keratoderma with erythema and overlying desquamation on the palmar surface, notably sparing the dorsal aspects of the fingers and nails. Accentuated skin markings can be appreciated on the volar wrist. (2A) Patient 2---AP photo demonstrating mild upslanting palpebral fissures on the left and a bulbous nasal tip with hypoplastic alae nasi. (2B) Lateral photo demonstrating normally formed ears with attached lobes; a nasal dimple; and micrognathia. (2C) A 0.9 mm thick axial T1 weighted image at the level of the insulae shows pronounced under-opercularisation with open Sylvian fissures and bilateral extensive thick nodular cortex representing polymicrogyria in all lobes of the brain, but most prominent in the insulae and the brain posterior to them. There is diminished white matter and abnormal gyral pattern throughout the brain. Also noted are anomalous deep fissures lined by the thick nodular cortex extending near to the ventricular atria and deforming them, more on the right. The genu of the corpus callosum is seen and the splenium, being very thin, is not included on this section. (2D) Anterior trunk showing diffuse xerosis and a fine, powdery, ichthyosiform scale which is accentuated on the arms. (2E) Bilateral plantar feet reveal a diffuse, glossy, yellowish keratoderma (thickening of the skin) with decreased skin markings and focal areas of desquamation on the heels. (2F) Right hand shows a diffuse, yellow-orange keratoderma with focal areas of desquamation on the palms and fingertips. (3A) Patient 3---AP photo demonstrating upslanting palpebral fissures with hypertelorism; malar flatness; a bulbous nasal tip with hypoplastic alae nasi, a blunted nasal tip with a dimple; asymmetric crying facies; and a healed tracheostomy scar. (3B) Lateral photo demonstrating auricular anomalies including crumpled helices with attached lobes and micrognathia. (4A) Patient 4---AP photo demonstrating hypertelorism; malar flatness; a bulbous nasal tip with hypoplastic alae nasi; and a repaired bilateral cleft lip and palate. (4B) Lateral photo demonstrating attached ear lobes and micrognathia.](jmedgenet-2012-101320f01){#JMEDGENET2012101320F1}

![Identification of a homozygous 2 bp frameshift insertion within the gene *SNAP29* by exome and Sanger sequencing. (A) The *SNAP29* gene is located on the long arm of chromosome 22 at position 22q11.2. It is 32 kb in size and is composed of five exons. (B) The grey horizontal arrows depict the 100 bp paired-end reads aligned to the positive strand of human genome (hg19) and cover the 2 bp 'GA' homozygous insertion at position 388_389 in exon 2. Of 19 unique reads mapped at the genomic position chr22:21224770, 17 reads displayed the 2 bp homozygous insertion. Note that the BWA (Burrows-Wheeler Aligner) placed the insertion at position c.383_384, whereas the correct HGVS (Human Genome Variation Society) notation is c.387_388dup. (C) Chromatograms show the result of Sanger sequencing in patient 1 and his parents. Patient 1 carries a homozygous 2 bp insertion resulting in a frameshift and a premature stop codon 17 amino acids downstream (p.T130fs). The father is a heterozygous carrier for the 2 bp insertion at the same position. The position of the insertion is indicated by the green arrow on the chromatograms of patient 1 and his father. In the lower part of figure, the frameshift DNA sequence and the respective translation into protein are given.](jmedgenet-2012-101320f02){#JMEDGENET2012101320F2}

In light of this finding, we concluded that the *SNAP29* mutation, in conjunction with the 22q11.2 deletion, unmasked the symptoms of CEDNIK syndrome in this patient, including diffuse polymicrogyria (similar to the 2011 Fuchs-Telem *et al* report[@R14]), an ichthyosiform dermatitis with secondary hypohidrosis, atopic dermatitis, and palmoplantar keratoderma. To determine if other patients with 22q11.2DS and similar atypical findings might also have mutations in this gene, we screened the coding exons 5′ and 3′ splice sites of *SNAP29* in 12 additional patients by Sanger sequencing. Thereafter, we identified a 5 bp deletion in exon 1 (c.28_32delCCGTT, p.P10fs) in patient 2 ([figure 3](#JMEDGENET2012101320F3){ref-type="fig"}B). Atypical findings in patient 2 included features consistent with CEDNIK syndrome, as well as with patient 1: microcephaly, polymicrogyria (similar to the structural differences reported by Sprecher *et al*[@R13]), optic nerve hypoplasia, hypertelorism, sensorineural hearing loss, palmoplantar keratoderma, and ichthyosis; additional findings also included a preauricular tag, amblyopia, hypospadias, and type 1 diabetes ([figure 1](#JMEDGENET2012101320F1){ref-type="fig"}: 2A--F and supplementary data). Sanger sequencing of DNA from the parents of this patient revealed the c.28_32delCCGTT mutation in the mother\'s DNA ([figure 3](#JMEDGENET2012101320F3){ref-type="fig"}B). This deletion is predicted to result in a frameshift insertion of 42 novel amino acids before a premature stop in the *SNAP29* protein ([figure 3](#JMEDGENET2012101320F3){ref-type="fig"}B). In addition, these studies also revealed a heterozygous A to G transition (c.317A\>G) that would generate a missense (p.Q106R) mutation in the father (see supplementary figure 1). Parent of origin studies, using microsatellite markers, revealed that the proband shares the D22S264 allele with his mother, indicating the 22q11.2 deletion was paternal in origin, consistent with the *SNAP29* findings.

![Schematic representation of *SNAP29* gene, cDNA and protein structure. (A) Upper panel is genomic structure of the *SNAP29* gene, comprises five exons (numbered 1--5) and 5′ and 3′ untranslated regions (UTRs). Introns are represented by a straight grey line. The structure of 777 bp *SNAP29* cDNA is shown in the middle panel. Numbers above the cDNA diagram show the exons (named E1--E5) boundary nucleotide. The vertical dashed grey lines align the location of each exon to the regions of *SNAP29* protein that each exon encodes. Numbers below the protein diagram show the contribution of each exon to the amino acid sequence. The *SNAP29* protein has a length of 258 amino acid residues and is composed of two domains: coiled-coil (orange box) and t-SNARE (purple box). The position of seven mutations identified in *SNAP29* is shown by arrows on cDNA and protein levels. The three mutations identified in this study are coloured in green for insertion and in red for deletion. Black arrows show the position of four previously reported *SNAP29* mutations, associated with cerebral dysgenesis, neuropathy, ichthyosis and keratoderma syndrome. (B) Sanger sequencing confirmed all of the mutations identified in this study. Patient 2 and his mother are homozygous for a 5 bp deletion (c.28_32delCCGTT) resulting in a frameshift (p.P10fs) and a premature stop codon 42 amino acids downstream. Patient 3 and 4 carry a homozygous sequence variant resulting in glutamic acid to lysine (p.E89K) and arginine to cysteine (p.R90C) changes, respectively.](jmedgenet-2012-101320f03){#JMEDGENET2012101320F3}

In a third patient (patient 3) with subglottic stenosis post-tracheostomy, cleft palate, sacral myelomeningocele, bilateral sensorineural hearing loss, tetralogy of Fallot with pulmonary atresia, hypocalcaemia, severe gastro-oesophageal reflux disease with feeding difficulty necessitating G-tube placement, asymmetric crying facies, hypocalcaemia, microcephaly, hypertelorism, clinodactyly, and hydronephrosis ([figure 1](#JMEDGENET2012101320F1){ref-type="fig"}: 3A,B), we identified a homozygous mutation (c.265G\>A) which resulted in a missense (p.E89K) mutation in a conserved glutamic acid. This mutation was not predicted to be damaging after PolyPhen-2 analysis with a score of 0.021. However, this specific mutation was predicted to be damaging by MutationTaster (p=0.94) and has been reported to be associated with genitourinary abnormalities in a previous study by Zhang *et al.*[@R15]

A fourth patient (patient 4) presented with a bilateral cleft lip and palate and pseudoexotropia secondary to hypertelorism as the only atypical features. Additional findings included an atrial septal defect, mild to moderate conductive hearing loss, hypocalcaemia, and hyperextensible joints ([figure 1](#JMEDGENET2012101320F1){ref-type="fig"}: 4A,B). Targeted exome sequencing identified and Sanger sequencing confirmed a second point mutation in the coiled-coil domain which resulted in a missense (c.268C\>T; p.R90C) mutation. This amino acid is highly conserved in all mammals but one, rodent (see supplementary figure 2), and is predicted to be damaging by MutationTaster (p=0.99) and possibly damaging by PolyPhen2, with a score of 0.890.

Discussion {#s4}
==========

Recurrent structural rearrangements in the human genome are responsible for a large number of human disorders associated with congenital abnormalities. Human deletion syndromes occur at a combined frequency of 1 in 1000 live births. Some examples include Prader-Willi,[@R26] Phelan-McDermid,[@R27] Williams-Bueren[@R28] and 22q11.2DS.[@R3] [@R11] [@R29] In many of these disorders, the recurrent deletion regions are defined within a certain range, the phenotypic defects constitute continuous spectra, there are a large number of genes contained within the candidate intervals, and it is unclear which gene(s) are primarily responsible for the observed phenotypic features.[@R30] Moreover, the phenotypic spectra are often broad, and many patients present with atypical or extreme phenotypes. Previously, identifying the breakpoints of the deletions and the genes contained within the structural rearrangements constituted the limit of resolution in determining the extent of genetic involvement. This resulted in numerous unanswered questions and speculation regarding the involvement of modifier genes and epigenetic effects as possible explanations for this phenotypic variability. However, as has been recently demonstrated in the case of Van den Ende Gupta syndrome,[@R12] [@R31] large deletions may unmask the deleterious effect of mutations on the homologous allele, resulting in loss of function.

Likewise, in 1995, we described the association of Bernard-Soulier syndrome,[@R32] an autosomal recessive condition involving thrombocytopenia and increased megakaryocytes, in a patient with 22q11.2DS, who was noted to have notably decreased ristoctein-induced platelet aggregation and GP1bB on the platelet surface by flow cytometry. Later, this was explained by a secondary mutation in the promoter region of the *GP1BB* gene on the remaining 22q11.2 allele that altered a GATA binding consensus site[@R32] [@R33] This mutation, in combination with the 22q11.2 deletion as is the case with the *SNAP29* abnormalities observed in patients 1 and 2 and their features of CEDNIK syndrome, essentially unmasked an autosomal recessive condition. Thus, our ability to identify such events will have a great impact on understanding the causative genes underlying human deletion syndromes, as well as understanding the function of previously uncharacterised genes which contribute to the unusual and extreme phenotypes observed in a subset of patients with 22q11.2DS.

Mutations in *SNAP29* are associated with CEDNIK syndrome and genitourinary malformations, and SNPs in the 5′ region have been associated with schizophrenia.[@R16] Four different mutations were previously reported in *SNAP29*: a homozygous c.486insA insertion which results in production of a truncated protein (p.S163fs);[@R14] a 1 bp deletion (c.220delG) which was predicted to also result in a truncated protein (p.V75fs) and was shown to result in loss of the protein by Western blot analysis;[@R13] and two heterozygous mutations, c.487A\>G and c.265G\>A of unknown status.[@R15] In this study, we report three novel mutations (c.388_389insGA, c.28_32delCCGTT, and c.268C\>T) in *SNAP29* that contribute to atypical findings in 22q11.2 patients as well as one previously reported mutation (c.265G\>A) ([figure 3](#JMEDGENET2012101320F3){ref-type="fig"}A).

*SNAP29* is a ubiquitous member of the t-SNARE proteins that forms a 4-helixes bundle with *SNAP23*, *SNAP25*, and *SNAP47* during vesicle docking at the plasma membrane.[@R34] *SNAP29* has also been shown to complex with several other proteins involved in vesicle secretion such as clathrin, alpha adaptin, APAP2, EHD1, and RAB3A.[@R34] [@R35] Loss of function mutations in this gene are associated with delayed maturation and secretion of lamellar granules that are involved in the transport of lipids and proteases to the epidermis.[@R36] More recently, *SNAP29* mutant cells were also shown to have abnormal endocytosis of β1-integrin, suggesting that abnormal cell migration may be contributing to the polymicrogyria phenotype found in patients.[@R19] Intriguingly, four of the seven mutations identified in this gene are before or in the coiled-coil domain of SNAP29 ([figure 3](#JMEDGENET2012101320F3){ref-type="fig"}A). This is a SNAP29 specific coiled-coil domain that is not shared by other related t-SNARE members. Since these domains are normally used for protein--protein interaction it is intriguing to postulate that mutations in this domain interfere with the efficiency of the interaction of SNAP29 with other SNARE proteins. This interference may result in abnormal interaction with specific associated SNAREs in a tissue dependent manner, thus explaining the variability in phenotypes found. In addition, although the E89K mutation is predicted to not be damaging by PolyPhen-2, this mutation is of an amino acid that is conserved in all primates and placental mammals. We postulate that this mutation is damaging as predicted by MutationTaster and thus likely to perturb SNAP29 function.

Two of the four patients described herein (patients 1 and 2) share a number of common clinical features: (1) an early-onset ichthyosiform presentation; (2) eventual development of palmoplantar keratoderma between 1--2 years of age that is accentuated at sites predisposed to pressure or friction; (3) features consistent with mild to moderate atopic dermatitis; and (4) hypohidrosis with associated heat intolerance (but without other features associated with hypohidrotic ectodermal dysplasia). The ichthyosiform skin changes and palmoplantar keratoderma are likely related to deficiency of the SNARE protein which plays a central role in Golgi function and synaptic vesicle recycling. The combination of the 22q11.2 deletion with a mutation in the remaining *SNAP29* allele encoding the SNARE protein presumably leads to significantly decreased expression of SNARE. As a result, the normal release of lipids and proteases from lamellar granules into the extracellular spaces of the cornified cell layer is likely impaired, resulting in defective desquamation and barrier formation. Defective barrier function may then lead to epicutaneous sensitisation and, secondarily, features of atopic dermatitis. Although the specific mechanism behind the hypohidrosis seen in both patients and the enamel hypoplasia in one of the two is unknown, these suggest that patients with these genetic changes may share features overlapping those of ectodermal dysplasia. In addition they both have polymicrogyria, hypertelorism/relative hypertelorism, bilateral sensorineural hearing loss, and significant feeding, swallowing and airway difficulties.

Patient 3 has several significant atypical findings including subglottic stenosis, bilateral sensorineural hearing loss, cleft palate, hypertelorism, a sacral myelomeningocele, and clinodactyly, in addition to classically associated features of 22q11.2DS such as tetralogy of Fallot with pulmonary atresia, asymmetric crying facies, and hypocalcaemia. This is notable because in 1984, Kousseff[@R37] reported the association of sacral meningocele, conotruncal cardiac anomalies, unilateral renal agenesis, and dysmorphic features in three siblings and suggested autosomal recessive inheritance. Toriello *et al*[@R38] reported a similar isolated case in 1985 and coined the term Kousseff syndrome. In 2002, Forrester *et al*[@R39] restudied the family reported by Kousseff and identified a 22q11.2 deletion in the proband and his father, thereby attributing the sacral myelomeningoceles to the 22q11.2DS. Thereafter, the existence of Kousseff syndrome as a distinct entity was called into question. However, in 2004, Maclean *et al*[@R40] subsequently reported two patients with Kousseff syndrome, one with a 22q11.2 deletion and the other without a deletion, both of which were performed by FISH, and concluded that Kousseff syndrome is causally heterogeneous. Perhaps the features in our patient 3 also represent the unmasking of an autosomal recessive condition, Kousseff, in the same manner as CEDNIK, with a deletion of 22q11.2 on one chromosome and a mutation in *SNAP29* on the other. Thus, we postulate that deletion of 22q11.2 on one chromosome associated with mutation(s) in *SNAP29* may also explain the presence of myelomeningoceles, a typically uncommon associated feature in 22q11.2DS, in a subset of Kousseff[@R37] patients.

Patient 4, presenting with a bilateral cleft lip and palate and hypertelorism also warrants further discussion as both features are reported in association with the 22q11.2 deletion, but infrequently. However it is notable that the combination of cleft lip and palate, hypertelorism, laryngotrachealesophageal anomalies and hypospadias has been described in individuals with the heterogeneous Opitz G/BBB syndrome,[@R41] where an X-linked form -- due to mutations in MID1 and an autosomal dominant form with linkage to 22q11.2, and an association with the 22q11.2 deletion syndrome have all been reported previously.[@R42; @R43; @R44; @R45; @R45] These individuals typically present with laryngo-tracheal-oesophageal abnormities, as seen in three of our four patients reported here with *SNAP29* mutations in combination with a 22q11.2 deletion, as well as: cleft lip and palate in one of four; hypertelorism in all four; severe swallowing difficulties/oesophageal dysmotility in three of four; and genitourinary abnormalities such as hypospadias in one of the two males and cryptorchidism in the other. Thus, *SNAP29* mutations in association with a 22q11.2 deletion may also elicit a set of symptoms previously described in association with Opitz G/BBB syndrome, and perhaps unmask an autosomal recessive phenocopy. This might also explain the child with 'apparent G syndrome' reported by Williams and Frias,[@R47] as well as isolated case reports such as the female described by Neri *et al.*[@R48] Furthermore, although *SNAP29* is known to be associated with schizophrenia we could not assess this condition in our patients. In fact, three of our four patients are below the age of onset, and the fourth patient, a young teen, is likely too impaired cognitively to assess for this phenotype.

In addition, in one patient (patient 1) we also identified a homozygous mutation in the *CLTCL1* gene that is predicted to be damaging. This variant in *CLTCL1* has previously been seen in the dbSNP, 1000 Genomes and three unrelated exome samples sequenced at our centre. *CLTCL1* encodes clathrin heavy chain-like 1, a major component of coated vesicles.[@R49] *CLTCL1* is not found in rodents and is predicted to function species-specifically in Glut4 transport in muscle cells, although it may also have functions in other tissues. Intriguingly, although the majority of abnormalities found in patient 1 can be explained by the mutation identified in *SNAP29*, this patient also had an unusual B cell immunity that may more likely be the result of the mutation in *CLTCL1*. Sequencing of additional patients will allow us to determine if the mutation in *CLTCL1* is associated with B cell abnormalities. However, since an atypical deletion that includes *SNAP29, LZTR1* and *P2RXL1* was recently found associated with immune deficiency, it remains possible that the mutations that we identified are responsible for this phenotype.[@R50]

In conclusion, we have found that mutations in a single gene, in unrelated patients, contribute to the phenotype of patients with a microdeletion syndrome, implicating *SNAP29* as a major modifier of variable expressivity in 22q11.2DS patients. Our work confirms that the phenotypic variability observed in patients with 22q11.2DS may be due to additional mutations on the non-deleted chromosome, which in some instances unmask a previously described autosomal recessive condition such as the CEDNIK and potentially Kousseff syndromes, and in other cases simply contributes to the presence of atypical findings. In fact, the majority of our patients did not have mutations in *SNAP29*, suggesting that non-coding mutations in *SNAP29*, and mutations in additional genes in the 22q11.2 region or on other chromosomes, are contributing to atypical findings in those patients, as previously suggested by Stalmans *et al.*[@R51] Future work is focused on identifying these additional mutations in the hope of stratifying patients for optimal treatment and genetic counselling.
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